phenyl acetate has been researched along with Viremia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gruber, J; Ingemi, AI; Khardori, N; McMahon, M; Pearston, AP; Ripley, K; Sutton, S; Wilson, TJ | 1 |
| Descourouez, JL; Garg, N; Jorgenson, MR; Mandelbrot, DA; Odorico, JS; Parajuli, S; Saddler, CM; Smith, JA | 1 |
| Papanicolaou, GA; Perales, MA | 1 |
| Arns, W; Beelen, DW; Budde, K; Dürr, M; Fischereder, M; Gwinner, W; Hummel, J; Lischka, P; Michel, D; Mühlfeld, A; Renders, L; Rübsamen-Schaeff, H; Stangl, M; Stoelben, S; Suwelack, B; Witzke, O; Zimmermann, H | 1 |
| Lischka, P; Michel, D; Zimmermann, H | 1 |
2 trial(s) available for phenyl acetate and Viremia
| Article | Year |
|---|---|
Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.
Topics: Acetates; Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Humans; Kidney Transplantation; Male; Middle Aged; Opportunistic Infections; Quinazolines; Viral Load; Viremia | 2014 |
Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228).
Topics: Acetates; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Viral; Humans; Open Reading Frames; Quinazolines; Viral Load; Viremia | 2016 |
3 other study(ies) available for phenyl acetate and Viremia
| Article | Year |
|---|---|
Successful Treatment of UL97 Mutation Ganciclovir-Resistant Cytomegalovirus Viremia in a Renal Transplant Recipient With Letermovir and Adjunct Hyperimmune Cytomegalovirus Immunoglobulin: A Case Report.
Topics: Acetates; Antibodies, Viral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Immunoglobulins, Intravenous; Kidney Transplantation; Male; Middle Aged; Mutation; Postoperative Complications; Quinazolines; Viral Load; Viremia | 2021 |
The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients.
Topics: Acetates; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Kidney Transplantation; Quinazolines; Transplant Recipients; Valganciclovir; Viremia | 2021 |
Cytomegalovirus Viremia and Death After Hematopoietic Cell Transplantation: More Complex Than "To Have and Have Not"?
Topics: Acetates; Cytomegalovirus; Cytomegalovirus Infections; Hematopoietic Stem Cell Transplantation; Humans; Quinazolines; Viremia | 2020 |